Fig. 3From: Urine metabolomics for assessing fertility-sparing treatment efficacy in endometrial cancer: a non-invasive approach using ultra-performance liquid chromatography mass spectrometryPathway enrichment analysis related to differential urine metabolites between pre-treatment and complete remission patientsBack to article page